Hjem › Inflammatorisk tarmsygdom › New Jersey
Inflammatorisk tarmsygdom kliniske forsøg i New Jersey
5 studier for Inflammatorisk tarmsygdom søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-014, Clifton
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Children's Hospital, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Atlantic Children's Health--Pediatric Gastroenterology, Morristown
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 24. aug. 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Goryeb Children's Hospital/Morristown Medical Center/Atlantic Children's Health, Morristown
RekruttererFase 4
Alder 6 til 17 · Alle køn · Opdateret 27. maj 2026 · NCT05781152Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.